Argyle Capital Management, LLC / JNJ
Argyle Capital Management, LLC’s Johnson & Johnson Position
Does Argyle Capital Management, LLC own Johnson & Johnson (JNJ)? Yes — 25.6K shares worth $6M (+2.04% of its 13F portfolio) as of Q1 2026, down from 25.9K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
25.6K
% of Portfolio
+2.04%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 25.6K | $6M | +2.04% |
| Q4 2025 | 25.9K | $5M | +1.79% |
| Q3 2025 | 25.9K | $5M | +1.66% |
| Q2 2025 | 25.9K | $4M | +1.43% |
| Q1 2025 | 26.0K | $4M | +1.60% |
| Q4 2024 | 25.8K | $4M | +1.47% |
| Q3 2024 | 24.1K | $4M | +1.56% |
| Q2 2024 | 24.8K | $4M | +1.49% |
| Q1 2024 | 23.8K | $4M | +1.46% |
| Q4 2023 | 23.2K | $4M | +1.51% |
| Q3 2023 | 28.2K | $4M | +1.61% |
| Q2 2023 | 28.2K | $5M | +1.68% |
| Q1 2023 | 30.3K | $5M | +1.65% |
| Q4 2022 | 30.3K | $5M | +1.84% |
| Q3 2022 | 30.4K | $5M | +1.93% |
| Q2 2022 | 30.4K | $5M | +1.93% |
| Q1 2022 | 30.4K | $5M | +1.75% |
| Q4 2021 | 31.3K | $5M | +1.67% |
| Q3 2021 | 32.0K | $5M | +1.71% |
| Q2 2021 | 32.2K | $5M | +1.71% |
| Q1 2021 | 32.4K | $5M | +1.80% |
| Q4 2020 | 32.5K | $5M | +1.90% |
| Q3 2020 | 33.8K | $5M | +2.06% |
| Q2 2020 | 35.0K | $5M | +2.07% |
| Q1 2020 | 35.0K | $5M | +2.17% |
| Q4 2019 | 35.0K | $5M | +1.81% |
| Q3 2019 | 35.0K | $5M | +1.71% |
| Q2 2019 | 35.0K | $5M | +1.85% |
| Q1 2019 | 35.7K | $5M | +1.92% |
| Q4 2018 | 35.7K | $5M | +1.95% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of JNJ.